Android app on Google Play

Roth Capital Starts TrovaGene (TROV) at Buy

December 20, 2012 7:28 AM EST Send to a Friend
Get Alerts TROV Hot Sheet
Price: $5.05 +0.20%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 26 | Down: 10 | New: 8
Trade TROV Now!
Join SI Premium – FREE
Roth Capital initiates coverage on TrovaGene (NASDAQ: TROV) with a Buy. PT $11.00.

For an analyst ratings summary and ratings history on TrovaGene click here. For more ratings news on TrovaGene click here.

Shares of TrovaGene closed at $6.91 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment